Global Osteoporosis Therapeutics Market Analysis 2016 - Forecast to 2022

  • ID: 3845820
  • Report
  • Region: Global
  • 135 pages
  • Hoovers Research
1 of 3
This analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis. The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments.

This report analyzes the global markets for "Osteoporosis Therapeutics". The market assessment is performed through standard and the tailored research methodology approach. The market overview offers in depth analysis at the regional and country level, for instance North America (U.S., Canada and Mexico), Europe (Germany, France, Italy, U.K. and Spain), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of APAC) and Rest of the World (Middle East, Africa and Latin America). Annual estimations and forecasts are provided from the year 2013 to 2022 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends.

Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities.

This report provides:
- Market Sizing estimations and forecasts for a minimum of 6 years of all the given segments, sub segments and the regional markets
- Identifying market dynamics (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Regional and country level market analysis
- Competitive landscaping mapping the key common trends
- Company profiling covering the financials, recent activities and the future strategies
- Supply chain trends mapping the recent advancements
- Strategic recommendations for the new entrants
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1 Introduction
1.1 Scope of the Report
1.2 Report Description
1.3 Research Methodology
1.4 Research Sources
1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Assumptions
1.5 List of Abbreviations

2 Executive Summary

3 Market Analysis
3.1 Market Segmentation
3.2 Market Size Estimation
3.3 Market Drivers
3.4 Market Constraints
3.5 Pipeline Analysis

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Osteoporosis Therapeutics Market by Product
5.1 Introduction
5.2 Dual-Acting Non-Bisphosphonates
5.2.1 Strontium Ranelate
5.3 Bisphosphonates
5.3.1 Alendronate
5.3.2 Boniva
5.3.3 Recalbon
5.3.4 Etidronate
5.3.5 Risedronate
5.4 Selective Estrogen Receptor Modulators (SERMs)
5.4.1 Evista
5.4.2 Viviant
5.5 Calcitonins
5.6 Parathyroid Hormone
5.6.1 Forteo (teriparatide)
5.7 Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL) Inhibitor
5.7.1 Prolia
5.8 Other products
5.8.1 Estrogen therapy
5.8.2 vitamin D and Calcium

6 Osteoporosis Therapeutics Market by Diagnostics Test
6.1 Introduction
6.2 Biomarkers
6.3 Conventional radiography tests
6.4 Dual-Energy X-Ray Test

7 Osteoporosis Therapeutics Market by Application
7.1 Introduction
7.2 Primary Type 1 Osteoporosis
7.3 Primary Type 2 Osteoporosis
7.4 Secondary Osteoporosis

8 Geographical Segmentation
8.1 North America
8.1.1 US
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia Pacific
8.4 RoW
8.4.1 Latin America
8.4.2 Middle East
8.4.3 Africa
8.4.4 Others

9 Vendor Landscaping
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiles
10.1 Amgen, Inc.
10.1.1 Business Overview
10.1.2 SWOT Analysis
10.1.3 Financial Overview
10.1.4 Strategy
10.1.5 Key Activities
10.2 Actavis plc
10.3 Eli Lilly and Company
10.4 F. Hoffmann-La Roche Ltd.
10.5 Merck & Co., Inc
10.6 Novartis International AG
10.7 Pfizer, Inc.
10.8 Novo Nordisk A/S
10.9 Teva Pharmaceutical Industries Ltd.
10.10 Radius Health
10.11 Ranbaxy laboratorie
10.12 Chugai pharmaceutical
10.13 Bone medical
10.14 Aegis therapeutics
10.15 AstraZeneca
10.16 GlaxoSmithKline (GSK)
10.17 OsteoGeneX
10.18 SmithKline Beecham plc
10.19 Taisho Pharmaceutical Holdings
10.20 Unigene Laboratories
10.21 Wyeth Pharmaceuticals

11 Appendix
12 Disclaimer

List of Tables
Table 1 Global Osteoporosis Therapeutics Market Analysis, by Region, 2013-2022 ($MN)
Table 2 Global Osteoporosis Therapeutics Market Analysis, by Product , 2013-2022 ($MN)
Table 3 Global Dual-Acting Non-Bisphosphonates Market Analysis, by Region , 2013-2022 ($MN)
Table 4 Global Dual-Acting Non-Bisphosphonates Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 5 Global Dual-Acting Non-Bisphosphonates Market Analysis, by Application , 2013-2022 ($MN)
Table 6 Global Bisphosphonates Market Analysis, by Region , 2013-2022 ($MN)
Table 7 Global Bisphosphonates Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 8 Global Bisphosphonates Market Analysis, by Application , 2013-2022 ($MN)
Table 9 Global Selective Estrogen Receptor Modulators (SERMs) Market Analysis, by Region , 2013-2022 ($MN)
Table 10 Global Selective Estrogen Receptor Modulators (SERMs) Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 11 Global Selective Estrogen Receptor Modulators (SERMs) Market Analysis, by Application , 2013-2022 ($MN)
Table 12 Global Calcitonins Market Analysis, by Region , 2013-2022 ($MN)
Table 13 Global Calcitonins Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 14 Global Calcitonins Market Analysis, by Application , 2013-2022 ($MN)
Table 15 Global Parathyroid Hormone Market Analysis, by Region , 2013-2022 ($MN)
Table 16 Global Parathyroid Hormone Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 17 Global Parathyroid Hormone Market Analysis, by Application , 2013-2022 ($MN)
Table 18 Global Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL) Inhibitor Market Analysis, by Region , 2013-2022 ($MN)
Table 19 Global Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL) Inhibitor Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 20 Global Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL) Inhibitor Market Analysis, by Application , 2013-2022 ($MN)
Table 21 Global Other products Market Analysis, by Region , 2013-2022 ($MN)
Table 22 Global Other products Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 23 Global Other products Market Analysis, by Application , 2013-2022 ($MN)
Table 24 Global Osteoporosis Therapeutics Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 25 Global Biomarkers Market Analysis, by Region , 2013-2022 ($MN)
Table 26 Global Biomarkers Market Analysis, by Product , 2013-2022 ($MN)
Table 27 Global Biomarkers Market Analysis, by Application , 2013-2022 ($MN)
Table 28 Global Conventional radiography tests Market Analysis, by Region , 2013-2022 ($MN)
Table 29 Global Conventional radiography tests Market Analysis, by Product , 2013-2022 ($MN)
Table 30 Global Conventional radiography tests Market Analysis, by Application , 2013-2022 ($MN)
Table 31 Global Dual-Energy X-Ray Test Market Analysis, by Region , 2013-2022 ($MN)
Table 32 Global Dual-Energy X-Ray Test Market Analysis, by Product , 2013-2022 ($MN)
Table 33 Global Dual-Energy X-Ray Test Market Analysis, by Application , 2013-2022 ($MN)
Table 34 Global Osteoporosis Therapeutics Market Analysis, by Application , 2013-2022 ($MN)
Table 35 Global Primary Type 1 Osteoporosis Market Analysis, by Region , 2013-2022 ($MN)
Table 36 Global Primary Type 1 Osteoporosis Market Analysis, by Product , 2013-2022 ($MN)
Table 37 Global Primary Type 1 Osteoporosis Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 38 Global Primary Type 2 Osteoporosis Market Analysis, by Region , 2013-2022 ($MN)
Table 39 Global Primary Type 2 Osteoporosis Market Analysis, by Product , 2013-2022 ($MN)
Table 40 Global Primary Type 2 Osteoporosis Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 41 Global Secondary Osteoporosis Market Analysis, by Region , 2013-2022 ($MN)
Table 42 Global Secondary Osteoporosis Market Analysis, by Product , 2013-2022 ($MN)
Table 43 Global Secondary Osteoporosis Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 44 North America Osteoporosis Therapeutics Market Analysis, by Country, 2013-2022 ($MN)
Table 45 North America Osteoporosis Therapeutics Market Analysis, by Product , 2013-2022 ($MN)
Table 46 North America Dual-Acting Non-Bisphosphonates Market Analysis, by Country , 2013-2022 ($MN)
Table 47 North America Dual-Acting Non-Bisphosphonates Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 48 North America Dual-Acting Non-Bisphosphonates Market Analysis, by Application , 2013-2022 ($MN)
Table 49 North America Bisphosphonates Market Analysis, by Country , 2013-2022 ($MN)
Table 50 North America Bisphosphonates Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 51 North America Bisphosphonates Market Analysis, by Application , 2013-2022 ($MN)
Table 52 North America Selective Estrogen Receptor Modulators (SERMs) Market Analysis, by Country , 2013-2022 ($MN)
Table 53 North America Selective Estrogen Receptor Modulators (SERMs) Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 54 North America Selective Estrogen Receptor Modulators (SERMs) Market Analysis, by Application , 2013-2022 ($MN)
Table 55 North America Calcitonins Market Analysis, by Country , 2013-2022 ($MN)
Table 56 North America Calcitonins Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 57 North America Calcitonins Market Analysis, by Application , 2013-2022 ($MN)
Table 58 North America Parathyroid Hormone Market Analysis, by Country , 2013-2022 ($MN)
Table 59 North America Parathyroid Hormone Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 60 North America Parathyroid Hormone Market Analysis, by Application , 2013-2022 ($MN)
Table 61 North America Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL) Inhibitor Market Analysis, by Country , 2013-2022 ($MN)
Table 62 North America Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL) Inhibitor Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 63 North America Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL) Inhibitor Market Analysis, by Application , 2013-2022 ($MN)
Table 64 North America Other products Market Analysis, by Country , 2013-2022 ($MN)
Table 65 North America Other products Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 66 North America Other products Market Analysis, by Application , 2013-2022 ($MN)
Table 67 North America Osteoporosis Therapeutics Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 68 North America Biomarkers Market Analysis, by Country , 2013-2022 ($MN)
Table 69 North America Biomarkers Market Analysis, by Product , 2013-2022 ($MN)
Table 70 North America Biomarkers Market Analysis, by Application , 2013-2022 ($MN)
Table 71 North America Conventional radiography tests Market Analysis, by Country , 2013-2022 ($MN)
Table 72 North America Conventional radiography tests Market Analysis, by Product , 2013-2022 ($MN)
Table 73 North America Conventional radiography tests Market Analysis, by Application , 2013-2022 ($MN)
Table 74 North America Dual-Energy X-Ray Test Market Analysis, by Country , 2013-2022 ($MN)
Table 75 North America Dual-Energy X-Ray Test Market Analysis, by Product , 2013-2022 ($MN)
Table 76 North America Dual-Energy X-Ray Test Market Analysis, by Application , 2013-2022 ($MN)
Table 77 North America Osteoporosis Therapeutics Market Analysis, by Application , 2013-2022 ($MN)
Table 78 North America Primary Type 1 Osteoporosis Market Analysis, by Country , 2013-2022 ($MN)
Table 79 North America Primary Type 1 Osteoporosis Market Analysis, by Product , 2013-2022 ($MN)
Table 80 North America Primary Type 1 Osteoporosis Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 81 North America Primary Type 2 Osteoporosis Market Analysis, by Country , 2013-2022 ($MN)
Table 82 North America Primary Type 2 Osteoporosis Market Analysis, by Product , 2013-2022 ($MN)
Table 83 North America Primary Type 2 Osteoporosis Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 84 North America Secondary Osteoporosis Market Analysis, by Country , 2013-2022 ($MN)
Table 85 North America Secondary Osteoporosis Market Analysis, by Product , 2013-2022 ($MN)
Table 86 North America Secondary Osteoporosis Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 87 Europe Osteoporosis Therapeutics Market Analysis, by Country, 2013-2022 ($MN)
Table 88 Europe Osteoporosis Therapeutics Market Analysis, by Product , 2013-2022 ($MN)
Table 89 Europe Dual-Acting Non-Bisphosphonates Market Analysis, by Country , 2013-2022 ($MN)
Table 90 Europe Dual-Acting Non-Bisphosphonates Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 91 Europe Dual-Acting Non-Bisphosphonates Market Analysis, by Application , 2013-2022 ($MN)
Table 92 Europe Bisphosphonates Market Analysis, by Country , 2013-2022 ($MN)
Table 93 Europe Bisphosphonates Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 94 Europe Bisphosphonates Market Analysis, by Application , 2013-2022 ($MN)
Table 95 Europe Selective Estrogen Receptor Modulators (SERMs) Market Analysis, by Country , 2013-2022 ($MN)
Table 96 Europe Selective Estrogen Receptor Modulators (SERMs) Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 97 Europe Selective Estrogen Receptor Modulators (SERMs) Market Analysis, by Application , 2013-2022 ($MN)
Table 98 Europe Calcitonins Market Analysis, by Country , 2013-2022 ($MN)
Table 99 Europe Calcitonins Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 100 Europe Calcitonins Market Analysis, by Application , 2013-2022 ($MN)
Table 101 Europe Parathyroid Hormone Market Analysis, by Country , 2013-2022 ($MN)
Table 102 Europe Parathyroid Hormone Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 103 Europe Parathyroid Hormone Market Analysis, by Application , 2013-2022 ($MN)
Table 104 Europe Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL) Inhibitor Market Analysis, by Country , 2013-2022 ($MN)
Table 105 Europe Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL) Inhibitor Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 106 Europe Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL) Inhibitor Market Analysis, by Application , 2013-2022 ($MN)
Table 107 Europe Other products Market Analysis, by Country , 2013-2022 ($MN)
Table 108 Europe Other products Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 109 Europe Other products Market Analysis, by Application , 2013-2022 ($MN)
Table 110 Europe Osteoporosis Therapeutics Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 111 Europe Biomarkers Market Analysis, by Country , 2013-2022 ($MN)
Table 112 Europe Biomarkers Market Analysis, by Product , 2013-2022 ($MN)
Table 113 Europe Biomarkers Market Analysis, by Application , 2013-2022 ($MN)
Table 114 Europe Conventional radiography tests Market Analysis, by Country , 2013-2022 ($MN)
Table 115 Europe Conventional radiography tests Market Analysis, by Product , 2013-2022 ($MN)
Table 116 Europe Conventional radiography tests Market Analysis, by Application , 2013-2022 ($MN)
Table 117 Europe Dual-Energy X-Ray Test Market Analysis, by Country , 2013-2022 ($MN)
Table 118 Europe Dual-Energy X-Ray Test Market Analysis, by Product , 2013-2022 ($MN)
Table 119 Europe Dual-Energy X-Ray Test Market Analysis, by Application , 2013-2022 ($MN)
Table 120 Europe Osteoporosis Therapeutics Market Analysis, by Application , 2013-2022 ($MN)
Table 121 Europe Primary Type 1 Osteoporosis Market Analysis, by Country , 2013-2022 ($MN)
Table 122 Europe Primary Type 1 Osteoporosis Market Analysis, by Product , 2013-2022 ($MN)
Table 123 Europe Primary Type 1 Osteoporosis Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 124 Europe Primary Type 2 Osteoporosis Market Analysis, by Country , 2013-2022 ($MN)
Table 125 Europe Primary Type 2 Osteoporosis Market Analysis, by Product , 2013-2022 ($MN)
Table 126 Europe Primary Type 2 Osteoporosis Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 127 Europe Secondary Osteoporosis Market Analysis, by Country , 2013-2022 ($MN)
Table 128 Europe Secondary Osteoporosis Market Analysis, by Product , 2013-2022 ($MN)
Table 129 Europe Secondary Osteoporosis Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 130 Asia Pacific Osteoporosis Therapeutics Market Analysis, by Country, 2013-2022 ($MN)
Table 131 Asia Pacific Osteoporosis Therapeutics Market Analysis, by Product , 2013-2022 ($MN)
Table 132 Asia Pacific Dual-Acting Non-Bisphosphonates Market Analysis, by Country , 2013-2022 ($MN)
Table 133 Asia Pacific Dual-Acting Non-Bisphosphonates Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 134 Asia Pacific Dual-Acting Non-Bisphosphonates Market Analysis, by Application , 2013-2022 ($MN)
Table 135 Asia Pacific Bisphosphonates Market Analysis, by Country , 2013-2022 ($MN)
Table 136 Asia Pacific Bisphosphonates Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 137 Asia Pacific Bisphosphonates Market Analysis, by Application , 2013-2022 ($MN)
Table 138 Asia Pacific Selective Estrogen Receptor Modulators (SERMs) Market Analysis, by Country , 2013-2022 ($MN)
Table 139 Asia Pacific Selective Estrogen Receptor Modulators (SERMs) Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 140 Asia Pacific Selective Estrogen Receptor Modulators (SERMs) Market Analysis, by Application , 2013-2022 ($MN)
Table 141 Asia Pacific Calcitonins Market Analysis, by Country , 2013-2022 ($MN)
Table 142 Asia Pacific Calcitonins Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 143 Asia Pacific Calcitonins Market Analysis, by Application , 2013-2022 ($MN)
Table 144 Asia Pacific Parathyroid Hormone Market Analysis, by Country , 2013-2022 ($MN)
Table 145 Asia Pacific Parathyroid Hormone Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 146 Asia Pacific Parathyroid Hormone Market Analysis, by Application , 2013-2022 ($MN)
Table 147 Asia Pacific Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL) Inhibitor Market Analysis, by Country , 2013-2022 ($MN)
Table 148 Asia Pacific Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL) Inhibitor Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 149 Asia Pacific Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL) Inhibitor Market Analysis, by Application , 2013-2022 ($MN)
Table 150 Asia Pacific Other products Market Analysis, by Country , 2013-2022 ($MN)
Table 151 Asia Pacific Other products Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 152 Asia Pacific Other products Market Analysis, by Application , 2013-2022 ($MN)
Table 153 Asia Pacific Osteoporosis Therapeutics Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 154 Asia Pacific Biomarkers Market Analysis, by Country , 2013-2022 ($MN)
Table 155 Asia Pacific Biomarkers Market Analysis, by Product , 2013-2022 ($MN)
Table 156 Asia Pacific Biomarkers Market Analysis, by Application , 2013-2022 ($MN)
Table 157 Asia Pacific Conventional radiography tests Market Analysis, by Country , 2013-2022 ($MN)
Table 158 Asia Pacific Conventional radiography tests Market Analysis, by Product , 2013-2022 ($MN)
Table 159 Asia Pacific Conventional radiography tests Market Analysis, by Application , 2013-2022 ($MN)
Table 160 Asia Pacific Dual-Energy X-Ray Test Market Analysis, by Country , 2013-2022 ($MN)
Table 161 Asia Pacific Dual-Energy X-Ray Test Market Analysis, by Product , 2013-2022 ($MN)
Table 162 Asia Pacific Dual-Energy X-Ray Test Market Analysis, by Application , 2013-2022 ($MN)
Table 163 Asia Pacific Osteoporosis Therapeutics Market Analysis, by Application , 2013-2022 ($MN)
Table 164 Asia Pacific Primary Type 1 Osteoporosis Market Analysis, by Country , 2013-2022 ($MN)
Table 165 Asia Pacific Primary Type 1 Osteoporosis Market Analysis, by Product , 2013-2022 ($MN)
Table 166 Asia Pacific Primary Type 1 Osteoporosis Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 167 Asia Pacific Primary Type 2 Osteoporosis Market Analysis, by Country , 2013-2022 ($MN)
Table 168 Asia Pacific Primary Type 2 Osteoporosis Market Analysis, by Product , 2013-2022 ($MN)
Table 169 Asia Pacific Primary Type 2 Osteoporosis Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 170 Asia Pacific Secondary Osteoporosis Market Analysis, by Country , 2013-2022 ($MN)
Table 171 Asia Pacific Secondary Osteoporosis Market Analysis, by Product , 2013-2022 ($MN)
Table 172 Asia Pacific Secondary Osteoporosis Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 173 RoW Osteoporosis Therapeutics Market Analysis, by Country, 2013-2022 ($MN)
Table 174 RoW Osteoporosis Therapeutics Market Analysis, by Product , 2013-2022 ($MN)
Table 175 RoW Dual-Acting Non-Bisphosphonates Market Analysis, by Country , 2013-2022 ($MN)
Table 176 RoW Dual-Acting Non-Bisphosphonates Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 177 RoW Dual-Acting Non-Bisphosphonates Market Analysis, by Application , 2013-2022 ($MN)
Table 178 RoW Bisphosphonates Market Analysis, by Country , 2013-2022 ($MN)
Table 179 RoW Bisphosphonates Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 180 RoW Bisphosphonates Market Analysis, by Application , 2013-2022 ($MN)
Table 181 RoW Selective Estrogen Receptor Modulators (SERMs) Market Analysis, by Country , 2013-2022 ($MN)
Table 182 RoW Selective Estrogen Receptor Modulators (SERMs) Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 183 RoW Selective Estrogen Receptor Modulators (SERMs) Market Analysis, by Application , 2013-2022 ($MN)
Table 184 RoW Calcitonins Market Analysis, by Country , 2013-2022 ($MN)
Table 185 RoW Calcitonins Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 186 RoW Calcitonins Market Analysis, by Application , 2013-2022 ($MN)
Table 187 RoW Parathyroid Hormone Market Analysis, by Country , 2013-2022 ($MN)
Table 188 RoW Parathyroid Hormone Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 189 RoW Parathyroid Hormone Market Analysis, by Application , 2013-2022 ($MN)
Table 190 RoW Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL) Inhibitor Market Analysis, by Country , 2013-2022 ($MN)
Table 191 RoW Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL) Inhibitor Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 192 RoW Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL) Inhibitor Market Analysis, by Application , 2013-2022 ($MN)
Table 193 RoW Other products Market Analysis, by Country , 2013-2022 ($MN)
Table 194 RoW Other products Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 195 RoW Other products Market Analysis, by Application , 2013-2022 ($MN)
Table 196 RoW Osteoporosis Therapeutics Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 197 RoW Biomarkers Market Analysis, by Country , 2013-2022 ($MN)
Table 198 RoW Biomarkers Market Analysis, by Product , 2013-2022 ($MN)
Table 199 RoW Biomarkers Market Analysis, by Application , 2013-2022 ($MN)
Table 200 RoW Conventional radiography tests Market Analysis, by Country , 2013-2022 ($MN)
Table 201 RoW Conventional radiography tests Market Analysis, by Product , 2013-2022 ($MN)
Table 202 RoW Conventional radiography tests Market Analysis, by Application , 2013-2022 ($MN)
Table 203 RoW Dual-Energy X-Ray Test Market Analysis, by Country , 2013-2022 ($MN)
Table 204 RoW Dual-Energy X-Ray Test Market Analysis, by Product , 2013-2022 ($MN)
Table 205 RoW Dual-Energy X-Ray Test Market Analysis, by Application , 2013-2022 ($MN)
Table 206 RoW Osteoporosis Therapeutics Market Analysis, by Application , 2013-2022 ($MN)
Table 207 RoW Primary Type 1 Osteoporosis Market Analysis, by Country , 2013-2022 ($MN)
Table 208 RoW Primary Type 1 Osteoporosis Market Analysis, by Product , 2013-2022 ($MN)
Table 209 RoW Primary Type 1 Osteoporosis Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 210 RoW Primary Type 2 Osteoporosis Market Analysis, by Country , 2013-2022 ($MN)
Table 211 RoW Primary Type 2 Osteoporosis Market Analysis, by Product , 2013-2022 ($MN)
Table 212 RoW Primary Type 2 Osteoporosis Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Table 213 RoW Secondary Osteoporosis Market Analysis, by Country , 2013-2022 ($MN)
Table 214 RoW Secondary Osteoporosis Market Analysis, by Product , 2013-2022 ($MN)
Table 215 RoW Secondary Osteoporosis Market Analysis, by Diagnostics Test , 2013-2022 ($MN)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll